Tate Deborah Taylor Sells 1,580 Shares of HealthStream (NASDAQ:HSTM) Stock

HealthStream, Inc. (NASDAQ:HSTM) Director Tate Deborah Taylor sold 1,580 shares of the firm’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $25.46, for a total transaction of $40,226.80. Following the completion of the transaction, the director directly owned 23,127 shares in the company, valued at approximately $588,813.42. This represents a 6.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

HealthStream Stock Up 0.9%

Shares of NASDAQ HSTM traded up $0.24 on Monday, hitting $25.39. The company had a trading volume of 157,797 shares, compared to its average volume of 182,259. The business has a 50 day moving average of $26.14 and a two-hundred day moving average of $27.02. The firm has a market capitalization of $753.12 million, a P/E ratio of 37.89, a PEG ratio of 3.08 and a beta of 0.43. HealthStream, Inc. has a 12-month low of $24.07 and a 12-month high of $34.24.

HealthStream (NASDAQ:HSTM) last posted its earnings results on Monday, November 3rd. The technology company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03. HealthStream had a net margin of 6.89% and a return on equity of 5.70%. The business had revenue of $76.47 million for the quarter, compared to analysts’ expectations of $75.52 million. HealthStream has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that HealthStream, Inc. will post 0.63 earnings per share for the current year.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were paid a dividend of $0.031 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Monday, November 17th. HealthStream’s dividend payout ratio is 17.65%.

HealthStream declared that its Board of Directors has authorized a stock buyback program on Tuesday, November 11th that authorizes the company to buyback $10.00 million in shares. This buyback authorization authorizes the technology company to purchase up to 1.3% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Virtus Advisers LLC acquired a new position in shares of HealthStream during the 3rd quarter valued at $142,000. Qube Research & Technologies Ltd raised its holdings in shares of HealthStream by 9.0% in the 3rd quarter. Qube Research & Technologies Ltd now owns 274,548 shares of the technology company’s stock worth $7,753,000 after purchasing an additional 22,595 shares in the last quarter. Numerai GP LLC bought a new stake in HealthStream during the third quarter worth approximately $1,911,000. Bank of America Corp DE increased its holdings in shares of HealthStream by 14.7% in the third quarter. Bank of America Corp DE now owns 162,048 shares of the technology company’s stock valued at $4,576,000 after buying an additional 20,766 shares in the last quarter. Finally, Aquatic Capital Management LLC acquired a new position in shares of HealthStream in the 3rd quarter worth $40,000. Institutional investors and hedge funds own 69.58% of the company’s stock.

Wall Street Analysts Forecast Growth

HSTM has been the subject of a number of research reports. Canaccord Genuity Group decreased their price target on HealthStream from $29.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, August 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of HealthStream in a research report on Wednesday, October 8th. Finally, Wall Street Zen downgraded HealthStream from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $28.00.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.